Ask AI
Tool for BTKi AEs in MCL
Interactive Tool to Guide the Management of BTK Inhibitor–Related Adverse Events in MCL

Released: April 27, 2026

Introduction

Use this Interactive Decision Support Tool to get expert recommendations on managing adverse events associated with BTK inhibitors when treating MCL.

Interactive Decision Support Tool

Interactive Tool to Guide the Management of BTK Inhibitor–Related Adverse Events in MCL

Disclaimer

Access to and use of this Interactive Decision Support Tool titled, “Interactive Tool to Guide the Management of BTK Inhibitor–Related Adverse Events in MCL” is provided subject to the following terms and conditions. PLEASE READ THESE TERMS CAREFULLY.

This Interactive Decision Support Tool is designed to educate healthcare professionals on making optimal management choices in monitoring and managing adverse events that can occur in patients with mantle cell lymphoma treated with BTK inhibitor therapy with expert guidance from Brad Kahl, MD; Kami Maddocks, MD; Javier Munoz, MD, MS, MBA, FACP; Tycel J. Phillips, MD; and Julie Vose, MD, MBA.

The material published by Decera Clinical Education reflects the views of the reviewers or authors of the Decera Clinical Education material, not those of Clinical Care Options, LLC dba Decera Clinical Education, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States FDA and/or the European Medicines Agency (EMA). A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Although the information contained in the “Interactive Tool to Guide the Management of BTK Inhibitor–Related Adverse Events in MCL” has been produced and processed from sources believed to be reliable, no warranty, expressed or implied, is made regarding the accuracy, adequacy, completeness, legality, reliability, or usefulness of any information. This disclaimer applies to both the isolated and aggregate uses of the information. Decera Clinical Education provides this information on an as-is basis. This disclaimer applies to all material published by Decera Clinical Education including but not limited to medical information or opinions. All warranties of any kind, expressed or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses, and noninfringement of proprietary rights are disclaimed.

Any trademarks are the property of respective companies.

© 2026 Decera Clinical Education. All rights reserved.

Program Content